Atezolizumab Trial in Endometrial Cancer - AtTEnd (Q61907500)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Atezolizumab Trial in Endometrial Cancer - AtTEnd |
clinical trial |
Statements
AtTEnd (English)
0 references
Phase III Double-blind Randomized Placebo Controlled Trial of Atezolizumab in Combination With Paclitaxel and Carboplatin in Women With Advanced/Recurrent Endometrial Cancer (English)
0 references
2 October 2018
0 references
July 2021
0 references
550
0 references
18 year
0 references